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Identity 
HGNC (Hugo): APC 
Location: 5q21 
 





15 exons (with a particularly large 15th exon). 
Transcription 
9.0 kb mRNA; 8538 bp open reading frame. 
Protein 
Description 
2843 amino acids; 310 kDa. 
Function 
APC is a classical tumour suppressor protein.  
The APC gene product indirectly regulates 
transcription of a number of critical cell proliferation 
genes, through its interaction with the transcription 
factor beta catenin. APC binding to beta catenin leads 
to ubiquitin-mediated beta catenin destruction; loss f 
APC function increases transcription of beta catenin 
targets. These targets include cyclin D, C-myc, ephrins 
and caspases. APC also interacts with numerous actin
and microtubule associated proteins. APC itself 
stabilizes microtubules.  
Homozygous APC truncation has been shown to affect 
chromosome attachment in cultured cells. Roles for 
APC in cell migration have been demonstrated in vitro 
and in mouse models. 
Homology 
A second family member, APC2, is located on 19p13.3 
(see non-annotated genes). 
Mutations 
Germinal 
Germline mutations of APC cause a spectrum of 
diseases under the broad category of familial 
adenomatous polyposis (FAP).  
Mutations typically cluster in or just distal to the 
armadillo repeat region and truncate the protein near its 
middle. It is not known which is pathophysiologic - 
absence of the full-length protein or presence of the 
truncated version; evidence exists for both. The second 
hit creates another truncation or gene deletion. There is  
some evidence that the position of the first hit in the  
gene determines the pattern of the second hit. 
Rare hypomorphic mutations cause attenuated 
polyposis. 










Both copies of the APC gene are mutated in 80% of 
sporadic colorectal tumours. 
Implicated in 
Familial Adenomatous Polyposis (FAP) 
Disease 
Autosomal dominant disease in which patients develop 
thousands of colonic polyps during childhood and 
adolescence. Many of these will progress to cancers if 
not removed. FAP encompasses other disease 
syndromes with extra-colonic manifestations. 
In Gardner Syndrome, patients may develop the 
following extra-intestinal manifestations: 
- Gastric and duodenal malignancies. 
- Cancer of the pancreas, biliary tree and gallbladder. 
- Hepatoblastoma. 
- Congenital hypertrophy of the retinal pigment 
epithelium (CHRPE), a benign hyperpigmentation 
beneath the retina that is typically asymptomatic. 
- Desmoid tumors, a tumor of the connective tissue that 
can cause morbidity and mortality by impinging on 
adjacent structures. 
- Osteomas and dental abnormalities. 
- Epidermoid cysts and other skin abnormalities. 
In a subset of patients with Turcot's syndrome, 
intestinal polyposis due to APC mutation is associated 
with brain tumors, especially meduloblastoma. 
Prognosis 
Without treatment, the life expectancy is in the early 
40s due to colon cancer.  
Treatment consists of regular screening, with 
polypectomy of large lesions. Due to the large number 
of polyps, eventual complete colectomy with or without 
proctosigmoidectomy is needed.  
Regular use of the cyclooxygenase inhibitor Sulindac 
and possibly other member of this class of drugs 
reduces the number of polyps. About ten percent of 
patients also experience significant morbidity from 
desmoid tumors. 
Sporadic colorectal cancer 
Disease 
Somatic mutation of the APC gene is found in the 
majority of colorectal adenocarcinomas. Sporadic 
colorectal cancer is the third most frequent cancer in 
the world. 
Prognosis 
The prognosis depends on the stage of the disease. 
Stage I lesions are usually cured by surgery. There is 
controversy about the use of chemotherapy in Stage II 
disease. In Stage III disease, chemotherapy improves 
the five year survival from ~50% to ~60%. 
Oncogenesis 
Loss of normal APC function is known to be an early 
event in both familial and sporadic colon cancer 
pathogenesis, occurring at the pre-adenoma stage. 
Current discussion is focused on whether loss of APC 
function precedes, follows, or is entwined with 
chromosomal instability. Later events include 
abnormalities of K-ras and p53. 
Generally colon cancers show either chromosomal 
instability (CIN), which correlates with loss of APC 
function, or microsatellite instability (MIN), which 
correlates with loss of mismatch repair function, but 
not both. 
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